Education
About Us
Working with TipRanks
Follow Us
Athira Pharma (ATHA)
NASDAQ:ATHA
Ath-1105
Healthy Volunteers
Phase I
Completed
A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105
May 17, 2024
―
Ath-1017
Alzheimer Disease
Phase II/III
Terminated
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
May 10, 2021
―
Ath-1017
Parkinson Disease Dementia, Dementia With Lewy Bodies
Phase II
Terminated
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)
Apr 01, 2021
―
Ath-1017
Alzheimer Disease, Dementia Of Alzheimer Type
Phase II/III
Completed
ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
Jul 23, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Athira Pharma (ATHA) have in its pipeline
ATHA is currently developing the following drugs: Ath-1105, Ath-1017, Ath-1017. These drug candidates are in various stages of clinical development as the company works toward FDA approval.